Live Breaking News & Updates on Eiger Biopharmaceuticals Inc

Stay updated with breaking news from Eiger biopharmaceuticals inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

AnGes : Notice Regarding the Decision to Sell the ZOKINVY Business of Eiger BioPharmaceuticals, Inc.

AnGes : Notice Regarding the Decision to Sell the ZOKINVY Business of Eiger BioPharmaceuticals, Inc.
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Eiger Zokinvy , Zydus Lifesciences Ltd , Us Bankruptcy Court , Eiger Biopharmaceuticals Inc , Sentynl Therapeutics Inc , Anges Inc , Company Name , Eiger Biopharmaceuticals , Sentynl Therapeutics , Zydus Lifesciences ,

StockNews.com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

StockNews.com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United States , Eiger Biopharmaceuticals Company Profile , Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals , Free Report , Get Free Report , Eiger Biopharmaceuticals Daily ,

Sentynl Therapeutics Announces Global Acquisition of Zokinvy® (Lonafarnib) for Treatment of Hutchinson-Gilford Progeria Syndrome from Eiger BioPharmaceuticals

/PRNewswire/ Sentynl Therapeutics, Inc. (Sentynl), a U.S.-based biopharmaceutical company wholly-owned by Zydus Lifesciences, Ltd. (Zydus Group), and Eiger. ....

United States , United Kingdom , Great Britain , Francis Collins , Zydus Lifesciences , Sam Berns , Progeroid Laminopathies , David Apelian , Eiger Zokinvy , Zokinvy Lonafarnib , Audrey Gordon , Sharvil Patel , Genetics Consortium , Zydus Group , University Of Washington , Ministry Of Health , International Patient Registry , Bankruptcy Court , National Institutes Of Health , Progeria Research Foundation , Eiger Biopharmaceuticals Inc , Prnewswire Sentynl Therapeutics Inc , Drug Administration , United States Bankruptcy Court , Merck Co Inc , Zydus Lifesciences Ltd ,

Head-To-Head Survey: Eiger BioPharmaceuticals (NASDAQ:EIGR) and XOMA (NASDAQ:XOMAP)

Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) and XOMA (NASDAQ:XOMAP – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, analyst recommendations, dividends, profitability, risk, institutional ownership and earnings. Insider and Institutional Ownership 62.5% of Eiger BioPharmaceuticals shares […] ....

United States , Palo Alto , Asia Pacific , Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals , Get Free Report , Given Eiger Biopharmaceutical , Eiger Biopharmaceuticals Daily , Nasdaq Eigr , Stock Comparison , Stock Analysis ,

StockNews.com Begins Coverage on Eiger BioPharmaceuticals (NASDAQ:EIGR)

Investment analysts at StockNews.com started coverage on shares of Eiger BioPharmaceuticals (NASDAQ:EIGR – Get Free Report) in a research note issued on Thursday. The firm set a “sell” rating on the biotechnology company’s stock. Eiger BioPharmaceuticals Price Performance Eiger BioPharmaceuticals has a 52-week low of $1.10 and a 52-week high of $43.35. The stock has […] ....

United States , Eiger Biopharmaceuticals Inc , Eiger Biopharmaceuticals , Get Free Report , Eiger Biopharmaceuticals Daily , Nasdaq Eigr , Initiated Coverage , Stocknews Com ,